Clinical trial
Alzheimer's Disease Prevention Trial
NCT00000176 · National Institute on Aging (NIA), NIH · Completed
Key facts
| NCT number | NCT00000176 |
|---|---|
| Title | Alzheimer's Disease Prevention Trial |
| Official title | Alzheimer's Disease Prevention Trial. A Multi-center, Randomized, Double-blind Placebo Controlled Trial of Estrogens to Prevent Alzheimer's Disease and Loss of Memory in Women. |
| Lead sponsor | National Institute on Aging (NIA), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Alzheimer Disease, Memory Disorders |
| Intervention type | Drug |
| Interventions | Estrogen, Estrogen and Progesterone |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Nov 1, 1999 |
| Last update posted | Nov 5, 2010 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: